candesartan cilexetil has been researched along with Diabetes Mellitus, Type 1 in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozdemir, S | 1 |
| Ugur, M | 1 |
| Gürdal, H | 1 |
| Turan, B | 1 |
1 other study available for candesartan cilexetil and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Treatment with AT(1) receptor blocker restores diabetes-induced alterations in intracellular Ca(2+) transients and contractile function of rat myocardium.
Topics: Action Potentials; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compou | 2005 |